Anthrax suspect commits suicide

A biodefense researcher committed suicide this week, just as the US government was about to indict him for the 2001 anthrax attacks that killed five people and caused a national panic. The microbiologist, Bruce E. Ivins, whose death was first reported today (August 1) in the linkurl:Los Angeles Times,;http://www.latimes.com/news/nationworld/nation/la-na-anthrax1-2008aug01,0,2864223.story?page=1, was a top scientist at a US Army biodefense research facility in Fort Detrick, Md., where he worked

Written byAlla Katsnelson
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
A biodefense researcher committed suicide this week, just as the US government was about to indict him for the 2001 anthrax attacks that killed five people and caused a national panic. The microbiologist, Bruce E. Ivins, whose death was first reported today (August 1) in the linkurl:Los Angeles Times,;http://www.latimes.com/news/nationworld/nation/la-na-anthrax1-2008aug01,0,2864223.story?page=1, was a top scientist at a US Army biodefense research facility in Fort Detrick, Md., where he worked on developing an anthrax vaccine. He was also closely involved in analyzing samples from the 2001 attacks. Ivins's suicide comes just a month after the US government paid out $5.8 million to settle a lawsuit brought by linkurl:Steven J. Hatfill,;http://www.the-scientist.com/blog/display/54807/ a biodefense researcher and colleague of Ivins and long the unofficial primary suspect in the case despite the absence of clear evidence. According to the Times, Army officials had questioned Ivins in 2001 because he had failed to report anthrax contaminations found in his office between December 2001 and April 2002. Ivins claimed that the contamination resulted from a lab technician's accidental spills, and he was not disciplined for keeping the spills secret. Investigators began to focus their suspicions on Ivins after a new team of investigators took charge of the anthrax case in late 2006, and began reexamining old leads. "He buckled under government pressure," Ivins's brother told the Times. He had not been publically named as a suspect in the case, however. According to the linkurl:Associated Press;http://www.nytimes.com/aponline/us/AP-Anthrax-Scientist.html?ref=us&pagewanted=print, the FBI was investigating whether Ivins had released the anthrax in order to test a vaccine he had developed. Government officials are expected to announce in the next several days whether his death will mean the close the investigation, or whether they believe Ivins acted with others, the AP reports.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies